Patricia Rodriguez-Martin
Las Palmas De Gran Canaria, CN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Endogenous LXR signaling controls pulmonary surfactant homeostasis and prevents lung inflammation.
Journal: Cellular and molecular life sciences : CMLS
Published: February 23, 2024
Reprogramming of the LXRα Transcriptome Sustains Macrophage Secondary Inflammatory Responses.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 28, 2023
Crosstalk Between LXR and Caveolin-1 Signaling Supports Cholesterol Efflux and Anti-Inflammatory Pathways in Macrophages.
Journal: Frontiers in endocrinology
Published: November 30, 2020
Synthesis and Antiplasmodial Activity of 1,2,3-Triazole-Naphthoquinone Conjugates.
Journal: Molecules (Basel, Switzerland)
Published: October 08, 2019
Correction: CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Journal: Oncotarget
Published: September 06, 2018
Lawsone, Juglone, and β-Lapachone Derivatives with Enhanced Mitochondrial-Based Toxicity.
Journal: ACS chemical biology
Published: June 08, 2018
A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells.
Journal: Frontiers in pharmacology
Published: April 20, 2018
In vitro activity of 1H-phenalen-1-one derivatives against Acanthamoeba castellanii Neff and their mechanisms of cell death.
Journal: Experimental parasitology
Published: July 14, 2017
5-Ethynylarylnaphthalimides as antitumor agents: Synthesis and biological evaluation.
Journal: Bioorganic & medicinal chemistry
Published: January 10, 2017
CM363, a novel naphthoquinone derivative which acts as multikinase modulator and overcomes imatinib resistance in chronic myelogenous leukemia.
Journal: Oncotarget
Published: April 23, 2016
Synthesis and study of antiproliferative, antitopoisomerase II, DNA-intercalating and DNA-damaging activities of arylnaphthalimides.
Journal: Bioorganic & medicinal chemistry
Published: July 01, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026